nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluridine—TK1—E2F transcription factor network—CDKN2C—ocular cancer	0.0299	0.0299	CbGpPWpGaD
Trifluridine—TYMS—Trans-sulfuration and one carbon metabolism—PSPH—ocular cancer	0.0291	0.0291	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—ID2—ocular cancer	0.025	0.025	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—E2F5—ocular cancer	0.0249	0.0249	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—E2F4—ocular cancer	0.0244	0.0244	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—MYBL2—ocular cancer	0.0244	0.0244	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—E2F2—ocular cancer	0.0239	0.0239	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—RBL1—ocular cancer	0.0239	0.0239	CbGpPWpGaD
Trifluridine—TYMS—G1/S-Specific Transcription—CDC25A—ocular cancer	0.0225	0.0225	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—RBL2—ocular cancer	0.022	0.022	CbGpPWpGaD
Trifluridine—TYMS—G1/S-Specific Transcription—TFDP1—ocular cancer	0.0219	0.0219	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—RBBP4—ocular cancer	0.0207	0.0207	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—E2F3—ocular cancer	0.0207	0.0207	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—CDC25A—ocular cancer	0.0197	0.0197	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—E2F3—ocular cancer	0.0195	0.0195	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—TFDP1—ocular cancer	0.0193	0.0193	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—CDC25A—ocular cancer	0.0185	0.0185	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—CCND3—ocular cancer	0.0175	0.0175	CbGpPWpGaD
Trifluridine—TYMS—E2F mediated regulation of DNA replication—CDC25A—ocular cancer	0.0132	0.0132	CbGpPWpGaD
Trifluridine—TYMS—E2F mediated regulation of DNA replication—TFDP1—ocular cancer	0.0129	0.0129	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—E2F1—ocular cancer	0.0127	0.0127	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—HDAC1—ocular cancer	0.0112	0.0112	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—CDKN2C—ocular cancer	0.0106	0.0106	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—CCND2—ocular cancer	0.0105	0.0105	CbGpPWpGaD
Trifluridine—TYMS—G1/S-Specific Transcription—E2F1—ocular cancer	0.0105	0.0105	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—CDK4—ocular cancer	0.0103	0.0103	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—E2F1—ocular cancer	0.00922	0.00922	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—RB1—ocular cancer	0.00899	0.00899	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—E2F5—ocular cancer	0.00883	0.00883	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—E2F4—ocular cancer	0.00865	0.00865	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—MYBL2—ocular cancer	0.00865	0.00865	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—E2F2—ocular cancer	0.00849	0.00849	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—RBL1—ocular cancer	0.00849	0.00849	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—CDK2—ocular cancer	0.00795	0.00795	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—RBL2—ocular cancer	0.00779	0.00779	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—MDM2—ocular cancer	0.00766	0.00766	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—E2F2—ocular cancer	0.00737	0.00737	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—E2F3—ocular cancer	0.00736	0.00736	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—RBBP4—ocular cancer	0.00736	0.00736	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—CDK4—ocular cancer	0.00706	0.00706	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—CDC25A—ocular cancer	0.007	0.007	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—TFDP1—ocular cancer	0.00684	0.00684	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—CCND1—ocular cancer	0.00667	0.00667	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—RB1—ocular cancer	0.00653	0.00653	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CDKN2C—ocular cancer	0.00649	0.00649	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—CDKN1A—ocular cancer	0.00646	0.00646	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—RBBP4—ocular cancer	0.00639	0.00639	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—E2F3—ocular cancer	0.00639	0.00639	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—CCND3—ocular cancer	0.0062	0.0062	CbGpPWpGaD
Trifluridine—TYMS—E2F mediated regulation of DNA replication—E2F1—ocular cancer	0.00617	0.00617	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—CDC25A—ocular cancer	0.00608	0.00608	CbGpPWpGaD
Trifluridine—TK1—Fluoropyrimidine Activity—TP53—ocular cancer	0.00603	0.00603	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—TFDP1—ocular cancer	0.00594	0.00594	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—E2F5—ocular cancer	0.0054	0.0054	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—CCND3—ocular cancer	0.00539	0.00539	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—MYC—ocular cancer	0.00535	0.00535	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—E2F4—ocular cancer	0.00529	0.00529	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—MYBL2—ocular cancer	0.00529	0.00529	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—E2F2—ocular cancer	0.00519	0.00519	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—RBL1—ocular cancer	0.00519	0.00519	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—CDKN1B—ocular cancer	0.00509	0.00509	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—CDC25A—ocular cancer	0.00508	0.00508	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—TFDP1—ocular cancer	0.00496	0.00496	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—RBL2—ocular cancer	0.00476	0.00476	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—CRTC1—ocular cancer	0.00472	0.00472	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—CDKN1A—ocular cancer	0.00469	0.00469	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—E2F3—ocular cancer	0.0045	0.0045	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—RBBP4—ocular cancer	0.0045	0.0045	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—EP300—ocular cancer	0.00447	0.00447	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—TP53—ocular cancer	0.0044	0.0044	CbGpPWpGaD
Trifluridine—TYMS—E2F mediated regulation of DNA replication—RB1—ocular cancer	0.00437	0.00437	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CDC25A—ocular cancer	0.00428	0.00428	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—ID2—ocular cancer	0.00421	0.00421	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—HRAS—ocular cancer	0.0042	0.0042	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—EP300—ocular cancer	0.00419	0.00419	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—TFDP1—ocular cancer	0.00418	0.00418	CbGpPWpGaD
Trifluridine—TYMP—Fluoropyrimidine Activity—TP53—ocular cancer	0.00418	0.00418	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—CDK6—ocular cancer	0.00402	0.00402	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00401	0.00401	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—HDAC1—ocular cancer	0.00397	0.00397	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00393	0.00393	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—MYC—ocular cancer	0.00389	0.00389	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CCND3—ocular cancer	0.00379	0.00379	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PSPH—ocular cancer	0.00366	0.00366	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—MYC—ocular cancer	0.00365	0.00365	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—HDAC1—ocular cancer	0.00345	0.00345	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—E2F1—ocular cancer	0.00327	0.00327	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—TP53—ocular cancer	0.003	0.003	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—E2F1—ocular cancer	0.00284	0.00284	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CDK6—ocular cancer	0.00283	0.00283	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—CDK2—ocular cancer	0.00282	0.00282	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PSPH—ocular cancer	0.00254	0.00254	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—CDK2—ocular cancer	0.00245	0.00245	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CCND2—ocular cancer	0.00243	0.00243	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—HDAC1—ocular cancer	0.00243	0.00243	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.00238	0.00238	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—E2F1—ocular cancer	0.00237	0.00237	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—RB1—ocular cancer	0.00232	0.00232	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—CDK4—ocular cancer	0.00232	0.00232	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CDKN2B—ocular cancer	0.00218	0.00218	CbGpPWpGaD
Trifluridine—TYMS—Fluoropyrimidine Activity—TP53—ocular cancer	0.00214	0.00214	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CDKN2C—ocular cancer	0.00213	0.00213	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—GNA11—ocular cancer	0.00211	0.00211	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—CDK2—ocular cancer	0.00205	0.00205	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.00201	0.00201	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—E2F1—ocular cancer	0.002	0.002	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—E2F5—ocular cancer	0.00198	0.00198	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—GNAQ—ocular cancer	0.00196	0.00196	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—E2F4—ocular cancer	0.00194	0.00194	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.00194	0.00194	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—E2F2—ocular cancer	0.0019	0.0019	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—RBL1—ocular cancer	0.0019	0.0019	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—CDKN1B—ocular cancer	0.0018	0.0018	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—E2F5—ocular cancer	0.00177	0.00177	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—HDAC1—ocular cancer	0.00177	0.00177	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—RBL2—ocular cancer	0.00175	0.00175	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—E2F4—ocular cancer	0.00174	0.00174	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—MYBL2—ocular cancer	0.00174	0.00174	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.00172	0.00172	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.00172	0.00172	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—E2F2—ocular cancer	0.0017	0.0017	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—RBL1—ocular cancer	0.0017	0.0017	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—RB1—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—CDKN1A—ocular cancer	0.00166	0.00166	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.00165	0.00165	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—E2F3—ocular cancer	0.00165	0.00165	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00165	0.00165	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.00163	0.00163	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—EP300—ocular cancer	0.00158	0.00158	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.00157	0.00157	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.00157	0.00157	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—RBL2—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.00153	0.00153	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00151	0.00151	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—E2F3—ocular cancer	0.00148	0.00148	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—RBBP4—ocular cancer	0.00148	0.00148	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.00145	0.00145	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—RB1—ocular cancer	0.00142	0.00142	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CDC25A—ocular cancer	0.0014	0.0014	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CCND3—ocular cancer	0.00139	0.00139	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—MYC—ocular cancer	0.00138	0.00138	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—TFDP1—ocular cancer	0.00137	0.00137	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—CDKN1B—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PSPH—ocular cancer	0.0013	0.0013	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CCND3—ocular cancer	0.00124	0.00124	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00123	0.00123	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—CDKN1A—ocular cancer	0.00121	0.00121	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.0012	0.0012	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—CDK4—ocular cancer	0.00119	0.00119	CbGpPWpGaD
Trifluridine—TK1—Metabolism—GNA11—ocular cancer	0.00115	0.00115	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.0011	0.0011	CbGpPWpGaD
Trifluridine—TK1—Metabolism—GNAQ—ocular cancer	0.00107	0.00107	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.00105	0.00105	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CDK6—ocular cancer	0.00104	0.00104	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—MYC—ocular cancer	0.001	0.001	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.000985	0.000985	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CDK6—ocular cancer	0.000927	0.000927	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000915	0.000915	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000891	0.000891	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000891	0.000891	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—MYC—ocular cancer	0.000844	0.000844	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000836	0.000836	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000799	0.000799	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—GNA11—ocular cancer	0.000798	0.000798	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000797	0.000797	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CCND2—ocular cancer	0.000797	0.000797	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—HDAC1—ocular cancer	0.000797	0.000797	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000771	0.000771	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—GNAQ—ocular cancer	0.000742	0.000742	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000734	0.000734	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000733	0.000733	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CDKN2B—ocular cancer	0.000714	0.000714	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—EP300—ocular cancer	0.000704	0.000704	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—E2F1—ocular cancer	0.000656	0.000656	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000639	0.000639	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000638	0.000638	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000632	0.000632	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000598	0.000598	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CDK2—ocular cancer	0.000565	0.000565	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CDK4—ocular cancer	0.000534	0.000534	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000525	0.000525	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—RB1—ocular cancer	0.00052	0.00052	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—TP53—ocular cancer	0.000504	0.000504	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—RB1—ocular cancer	0.000465	0.000465	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000443	0.000443	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GNA11—ocular cancer	0.000408	0.000408	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000405	0.000405	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—MDM2—ocular cancer	0.000396	0.000396	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000386	0.000386	CbGpPWpGaD
Trifluridine—TK1—Metabolism—EP300—ocular cancer	0.000385	0.000385	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GNAQ—ocular cancer	0.00038	0.00038	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000373	0.000373	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CDKN1B—ocular cancer	0.000362	0.000362	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—EP300—ocular cancer	0.000355	0.000355	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CCND1—ocular cancer	0.000345	0.000345	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CDKN1A—ocular cancer	0.000334	0.000334	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—EP300—ocular cancer	0.000318	0.000318	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—MYC—ocular cancer	0.00031	0.00031	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—MYC—ocular cancer	0.000277	0.000277	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—EP300—ocular cancer	0.000267	0.000267	CbGpPWpGaD
Trifluridine—TK1—Metabolism—AKT1—ocular cancer	0.000233	0.000233	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—TP53—ocular cancer	0.000227	0.000227	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—AKT1—ocular cancer	0.000161	0.000161	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—EP300—ocular cancer	0.000136	0.000136	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—AKT1—ocular cancer	8.25e-05	8.25e-05	CbGpPWpGaD
